Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001104659-26-126822·Beam Therapeutics Inc.
Schedule 13G ownership disclosure
Beam Therapeutics Inc
Common Stock · CUSIP: 07373V105
Event date: 2026-09-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- ARK Investment Management LLC
Shares: 11,805,372.00 · Class: 11.43%
- Catherine D. Wood
Shares: 11,805,372.00 · Class: 11.43%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-26-126822
- Form type
- SCHEDULE 13G/A
- Filer
- Beam Therapeutics Inc.
- CIK
- CIK 1745999
- Filed
- Nov 13, 2026
- Reporting period
- Sep 30, 2026
- Description
- Schedule 13G beneficial ownership